165 related articles for article (PubMed ID: 26809940)
1. Management of bone mineral density in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options for low bone mineral density in HIV-infected subjects.
Cotter AG; Mallon PW
Curr HIV/AIDS Rep; 2012 Jun; 9(2):148-59. PubMed ID: 22528765
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density loss, osteoporosis, and fractures in HIV.
Labarga P
AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
[TBL] [Abstract][Full Text] [Related]
4. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.
Walker Harris V; Brown TT
J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S391-8. PubMed ID: 22577213
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients.
Negredo E; Warriner AH
Curr Opin HIV AIDS; 2016 May; 11(3):351-7. PubMed ID: 26890207
[TBL] [Abstract][Full Text] [Related]
6. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
McGinty T; Mallon P
Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
[TBL] [Abstract][Full Text] [Related]
7. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR; Moreno S; Cacopardo B; Nunnari G
AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
[TBL] [Abstract][Full Text] [Related]
8. Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient.
Hoy J
Drugs Aging; 2015 Jul; 32(7):549-58. PubMed ID: 26123948
[TBL] [Abstract][Full Text] [Related]
9. Bone health and human immunodeficiency virus infection.
Schafer JJ; Manlangit K; Squires KE
Pharmacotherapy; 2013 Jun; 33(6):665-82. PubMed ID: 23553497
[TBL] [Abstract][Full Text] [Related]
10. HIV infection and bone disease: implications for an aging population.
Cotter AG; Mallon PW
Sex Health; 2011 Dec; 8(4):493-501. PubMed ID: 22127034
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic management of bone demineralization in the HIV-infected population.
Negredo E; Martínez E; Cinquegrana D; Estany C; Clotet B
AIDS; 2007 Mar; 21(6):657-63. PubMed ID: 17413686
[No Abstract] [Full Text] [Related]
12. [Are bones in HIV-infected patient really fragile?].
Biver E; Ciaffi L; Rizzoli R; Calmy A
Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
Escota GV; Mondy K; Bush T; Conley L; Brooks JT; Önen N; Patel P; Kojic EM; Henry K; Hammer J; Wood KC; Lichtenstein KA; Overton ET
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):59-67. PubMed ID: 26366785
[TBL] [Abstract][Full Text] [Related]
14. Bone health in HIV infection.
Pollock E; Klotsas AE; Compston J; Gkrania-Klotsas E
Br Med Bull; 2009; 92():123-33. PubMed ID: 19875393
[TBL] [Abstract][Full Text] [Related]
15. [The significance of HIV to bone mineral density].
Wessman M; Weis N; Katzenstein TL; Lebech AM; Thorsteinsson K; Hansen AE; Jensen JB
Ugeskr Laeger; 2017 Sep; 179(36):. PubMed ID: 28874254
[TBL] [Abstract][Full Text] [Related]
16. Bone changes and fracture risk in individuals infected with HIV.
Warriner AH; Mugavero MJ
Curr Rheumatol Rep; 2010 Jun; 12(3):163-9. PubMed ID: 20425517
[TBL] [Abstract][Full Text] [Related]
17. Odanacatib for the treatment of osteoporosis.
Boggild MK; Gajic-Veljanoski O; McDonald-Blumer H; Ridout R; Tile L; Josse R; Cheung AM
Expert Opin Pharmacother; 2015; 16(11):1717-26. PubMed ID: 26149759
[TBL] [Abstract][Full Text] [Related]
18. Monitoring and assessment of bone mineral density in HIV-infected individuals.
Lawrence D; Cresswell F; Jones E; Jarrett P; Mowete C; Gilleece Y
Sex Transm Infect; 2016 Dec; 92(8):592. PubMed ID: 27864438
[No Abstract] [Full Text] [Related]
19. Bone alterations associated with HIV.
Warriner AH; Mugavero M; Overton ET
Curr HIV/AIDS Rep; 2014 Sep; 11(3):233-40. PubMed ID: 25064454
[TBL] [Abstract][Full Text] [Related]
20. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
Clay PG; Voss LE; Williams C; Daume EC
Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
